Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Radiotherapy plus anti-PD1 versus radiotherapy for hepatic toxicity in patients with hepatocellular carcinoma.
Radiat Oncol. 2023 Aug 4;18(1):129. doi: 10.1186/s13014-023-02309-1.
Radiat Oncol. 2023.
PMID: 37542246
Free PMC article.
PURPOSE: In this study, we aimed to compare the radiation-induced hepatic toxicity (RIHT) outcomes of radiotherapy (RT) plus antibodies against programmed cell death protein 1 (anti-PD1) versus RT alone in patients with hepatocellular carcinoma (HCC), evaluate prognostic f …
PURPOSE: In this study, we aimed to compare the radiation-induced hepatic toxicity (RIHT) outcomes of radiotherapy (RT) plus antibodies agai …
Establishment and validation of a prognostic pomogram in unresectable hepatocellular carcinoma treated with intensity modulated radiotherapy: a real world study.
Long M, Li J, He M, Qiu J, Zhang R, Liu Y, Liang C, Lu H, Pang Y, Zhou H, Yu H, Qiu M.
Long M, et al.
Radiat Oncol. 2023 Jun 7;18(1):96. doi: 10.1186/s13014-023-02292-7.
Radiat Oncol. 2023.
PMID: 37287040
Free PMC article.
Item in Clipboard
Cite
Cite